Outcome of Board Meeting
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, inter alia, took on record the resignation of Ms. Manisha Girotra as Independent Director of the Company w.e.f. February 11, 2016. Financial Results, Limited Review Report for December 31, 2015
Novartis India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Limited Review for the period ended December 31, 2015 Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Novartis India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Slump Sale of Novartis India Limiteds Animal Health Division - Transaction Update
Novartis India Ltd has informed BSE regarding "Slump Sale of Novartis India Limiteds Animal Health Division - Transaction Update". Slump Sale of Novartis India Limiteds Animal Health Division - Transaction Update
Novartis India Ltd has informed BSE regarding "Slump Sale of Novartis India Limiteds Animal Health Division - Transaction Update". Authorised KMPs to determine materiality of events/information
Novartis India Ltd has informed BSE regarding Authorised Key Managerial Personnel to determine materiality of events/information. Financial Results with Results Press Release & Limited Review Report for Sept 30, 2015 (Standalone)
Novartis India Ltd has informed BSE about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2015. Shareholding Pattern for September 30, 2015
Novartis India Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Transfer of Novartis India Limiteds OTC Division - Transaction Update
With reference to the earlier announcements on January 13, 2015 and August 28, 2015 respectively, and in light of recent developments, Novartis India Limited has now informed BSE an update on the status of the transfer of the Companys OTC Division to GlaxoSmithKline Consumer Private Limited (GSK CPL), a private unlisted company incorporated under the Companies Act, 2013.... Slump Sale of Novartis India Limiteds Animal Health Division - Transaction Update
Novartis India Ltd has informed BSE regarding "Slump Sale of Novartis India Limiteds Animal Health Division - Transaction Update".